Citation Impact
Citing Papers
Measuring the Global Burden of Disease
2013 Standout
Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trial
2012
The personal and national costs of lost labour force participation due to arthritis: an economic study
2013
The economics of treatment in early rheumatoid arthritis
2009
Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent
2001 Standout
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
2008 Standout
Osteoporosis
2019 Standout
Drug-free remission, functioning and radiographic damage after 4 years of response-driven treatment in patients with recent-onset rheumatoid arthritis
2008
Rheumatoid arthritis
2016 Standout
Synovial Tissue Inflammation Mediated by Autoimmune T Cells
2019 StandoutNobel
When does rheumatoid arthritis begin and why do we need to know?
2000
A simplified disease activity index for rheumatoid arthritis for use in clinical practice
2003
The relationship between infliximab treatment and lymphoma in Crohn's disease
1999
Current risk factors for work disability associated with rheumatoid arthritis: Recent data from a US national cohort
2009
Diagnosis of osteoporosis and assessment of fracture risk
2002 Standout
A meta-analysis of the efficacy and toxicity of combining disease-modifying anti-rheumatic drugs in rheumatoid arthritis based on patient withdrawal
2005
Preference for nonsteroidal antiinflammatory drugs over acetaminophen by rheumatic disease patients: A survey of 1,799 patients with osteoarthritis, rheumatoid arthritis, and fibromyalgia
2000
Hallmarks of aging: An expanding universe
2023 Standout
Juvenile idiopathic arthritis
2007 Standout
Mindfulness meditation alleviates depressive symptoms in women with fibromyalgia: Results of a randomized clinical trial
2007
Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial
1999 Standout
Vitamin D Deficiency
2007 Standout
Management of Fibromyalgia Syndrome
2004
EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)
2006
Efficacy and safety of alendronate for the treatment of osteoporosis in diffuse connective tissue diseases in children: A prospective multicenter study
2000
Systemic sclerosis
2017 Standout
Efficacy of B-Cell–Targeted Therapy with Rituximab in Patients with Rheumatoid Arthritis
2004 Standout
Quality of Reporting of Observational Longitudinal Research
2005
The Pathogenesis of Rheumatoid Arthritis
2011 Standout
Gout
2009 Standout
Osteoarthritis
2015 Standout
What Is the Effect of Physical Activity on the Knee Joint? A Systematic Review
2010
Influence of variation in semiflexed knee positioning during image acquisition on separate quantitative radiographic parameters of osteoarthritis, measured by Knee Images Digital Analysis
2012
Atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus
2008
Cytokine Pathways and Joint Inflammation in Rheumatoid Arthritis
2001 Standout
How to diagnose rheumatoid arthritis early: A prediction model for persistent (erosive) arthritis
2002
Lost Productive Time and Cost Due to Common Pain Conditions in the US Workforce
2003 Standout
Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis
2000 Standout
Infliximab Maintenance Therapy for Fistulizing Crohn's Disease
2004 Standout
Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid Arthritis
2000 Standout
The health assessment questionnaire (HAQ) is strongly predictive of good outcome in early diffuse scleroderma: results from an analysis of two randomized controlled trials in early diffuse scleroderma
2004
Employment, work disability, and work days lost in patients with ankylosing spondylitis: a cross sectional study of Dutch patients
2001
The prevalence and characteristics of fibromyalgia in the general population
1995 Standout
A prospective, longitudinal, multicenter study of service utilization and costs in fibromyalgia
1997
Gout in the Elderly
1998
OA guidelines: improving care or merely codifying practice?
2014
A systematic search and critical review of measures of disability for use in a population survey of hand osteoarthritis (OA)
2004
Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial
2002 Standout
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
EULAR recommendations for the use of imaging in the clinical management of peripheral joint osteoarthritis
2017
Epidemiology of Vertebral Fractures
2015
Inflammation and cancer: back to Virchow?
2001 Standout
Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: A randomized, controlled trial
2004
A Comparison of Etanercept and Methotrexate in Patients with Early Rheumatoid Arthritis
2000 Standout
The development of folate-PAMAM dendrimer conjugates for targeted delivery of anti-arthritic drugs and their pharmacokinetics and biodistribution in arthritic rats
2006
Rheumatoid arthritis
2010 Standout
Subgroup analyses of the effectiveness of oral glucosamine for knee and hip osteoarthritis: a systematic review and individual patient data meta-analysis from the OA trial bank
2017
OARSI recommendations for the management of hip and knee osteoarthritis
2010
Special article the economic cost and social and psychological impact of musculoskeletal conditions
1995
Nabilone for the Treatment of Pain in Fibromyalgia
2007
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies
2007 Standout
Therapeutic strategies for rheumatoid arthritis
2003
Reduction in long‐term disability in patients with rheumatoid arthritis by disease‐modifying antirheumatic drug–based treatment strategies
1996
Polymyalgia Rheumatica and Giant-Cell Arteritis
2002 Standout
Febuxostat Compared with Allopurinol in Patients with Hyperuricemia and Gout
2005 Standout
Adverse outcomes of antiinflammatory therapy among patients with polymyalgia rheumatica
1997
Quality criteria were proposed for measurement properties of health status questionnaires
2006 Standout
A Randomized Trial of Tai Chi for Fibromyalgia
2010 Standout
Rheumatoid arthritis: Disappointing long-term outcomes despite successful short-term clinical trials
1988
The TNF and TNF Receptor Superfamilies
2001 Standout
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
2007 Standout
OARSI Clinical Trials Recommendations: Hip imaging in clinical trials in osteoarthritis
2015
Osteoarthritis
2019 Standout
Exploring the full spectrum of macrophage activation
2008 Standout
External validity of randomised controlled trials: “To whom do the results of this trial apply?”
2005 Standout
Anti-TNF Antibody Therapy in Rheumatoid Arthritis and the Risk of Serious Infections and Malignancies
2006 Standout
Lymphoma in rheumatoid arthritis: The effect of methotrexate and anti–tumor necrosis factor therapy in 18,572 patients
2004
Prevention and treatment of glucocorticoid-induced osteoporosis with active vitamin D3 analogues: a review with meta-analysis of randomized controlled trials including organ transplantation studies
2004
Radiographic changes in rheumatoid arthritis patients attaining different disease activity states with methotrexate monotherapy and infliximab plus methotrexate: the impacts of remission and tumour necrosis factor blockade
2008
Reassessment of Twelve Traditional Paradigms Concerning the Diagnosis, Prevalence, Morbidity and Mortality of Rheumatoid Arthritis
1989
Is DAS28 an appropriate tool to assess remission in rheumatoid arthritis?
2005
Comorbidities in rheumatoid arthritis
2007
Anti-Cytokine Therapy for Rheumatoid Arthritis
2000
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Outcome evaluations in gout.
2007
Risk of Bias and Brand Explain the Observed Inconsistency in Trials on Glucosamine for Symptomatic Relief of Osteoarthritis: A Meta‐Analysis of Placebo‐Controlled Trials
2014
Diagnosis and Treatment of Hip and Knee Osteoarthritis
2021 Standout
Chondroitin for osteoarthritis
2015
Treatment of Very Early Rheumatoid Arthritis With Symptomatic Therapy, Disease-Modifying Antirheumatic Drugs, or Biologic Agents
2009
Combination therapy versus monotherapy for the treatment of patients with rheumatoid arthritis.
2000
Functional Nanomaterials for Phototherapies of Cancer
2014 Standout
Use of Oral Corticosteroids and Risk of Fractures
2000 Standout
Knee osteoarthritis has doubled in prevalence since the mid-20th century
2017 Standout
Current status and future prospects for disease modification in osteoarthritis
2017
Glucocorticoid Osteoporosis
1999
Interleukin-10 and the Interleukin-10 Receptor
2001 Standout
A Test of Pre–Main‐Sequence Evolutionary Models across the Stellar/Substellar Boundary Based on Spectra of the Young Quadruple GG Tauri
1999 StandoutNobel
Glucosamine/Chondroitin and Mortality in a US NHANES Cohort
2020
Unresolved Questions in Rheumatology: Motion for Debate: Osteoarthritis Clinical Trials Have Not Identified Efficacious Therapies Because Traditional Imaging Outcome Measures Are Inadequate
2013
Joint British Societies’ consensus recommendations for the prevention of cardiovascular disease (JBS3)
2014
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies
2007 Standout
Cannabinoids for Medical Use
2015 Standout
Use of Inhaled Corticosteroids and Risk of Fractures
2001 Standout
Mortality in rheumatoid arthritis: 2008 update.
2009
Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine
2010 Standout
Osteoarthritis: an update with relevance for clinical practice
2011 Standout
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Works of Fred Wolfe being referenced
50 years of antirheumatic therapy: the prognosis of rheumatoid arthritis.
1990
Fractures in rheumatoid arthritis: an evaluation of associated risk factors.
1993
The longterm outcomes of rheumatoid arthritis: Work disability: a prospective 18 year study of 823 patients.
1998
Clinical efficacy and safety of glucosamine, chondroitin sulphate, their combination, celecoxib or placebo taken to treat osteoarthritis of the knee: 2-year results from GAIT
2010
Biologic drugs for rheumatoid arthritis in the medicare program: A cost‐effectiveness analysis
2008
Patient repositioning reproducibility of joint space width measurements on hand radiographs
2010
The effect of glucosamine and/or chondroitin sulfate on the progression of knee osteoarthritis: A report from the glucosamine/chondroitin arthritis intervention trial
2008
Remission in rheumatoid arthritis.
1985
Influence of nonclassical cardiovascular risk factors on the accuracy of predicting subclinical atherosclerosis in rheumatoid arthritis.
2007
Prevalence of primary and secondary fibrositis.
1983
Prospective 5-year followup of recombinant interferon-gamma in rheumatoid arthritis.
1990
Upper and lower airway disease in penicillamine treated patients with rheumatoid arthritis.
1983
Marital status in rheumatoid arthritis and other rheumatic disorders: a study of 7,293 patients.
1991
Gout and hyperuricemia.
1991
Evaluation and documentation of rheumatoid arthritis disease status in the clinic: which variables best predict change in therapy.
2001
The prognosis of rheumatoid arthritis and undifferentiated polyarthritis syndrome in the clinic: a study of 1141 patients.
1993
Lymphoma and Luekemia in Rheumatoid Arthritis
1996
Use of combination therapy in the routine care of patients with rheumatoid arthritis: physician and patient surveys.
2000
Measuring the epidemiology of distress: the rheumatology distress index.
2000
Critical issues in longitudinal and observational studies: purpose, short versus long term, selection of study instruments, methods, outcomes, and biases.
1999